- Home
- Brussels
- Company regulated news
- Archive
- Company press releases
Company press releases
Released | Company | Title | Industry | Topic |
---|---|---|---|---|
21 Apr 2023 07:00 CEST |
NYRSTAR | Nyrstar NV 2022 Full Year Results | 55102050 Nonferrous Metals | Other subject |
20 Apr 2023 22:30 CEST |
NYXOAH SA | Publication Relating to Transparency Notifications | 20102010 Medical Equipment | Other subject |
20 Apr 2023 22:30 CEST |
NYXOAH SA | Publication Relative à des Notifications de Transparence | 20102010 Medical Equipment | Other subject |
20 Apr 2023 18:10 CEST |
DMS IMAGING | Record quarterly revenue: EUR 10.1 million in the 1st quarter of 2023, organic growth +16% - Confirmation of 2023 targets and perspectives | 20103010 Biotechnology | Sales, Income |
20 Apr 2023 18:00 CEST |
DMS IMAGING | Chiffre d'affaires trimestriel record : 10,1 M EUR au 1er trimestre 2023 en croissance organique de +16% - Confirmation des objectifs 2023 | 20103010 Biotechnology | Sales, Income |
20 Apr 2023 18:00 CEST |
VAN DE VELDE | VAN DE VELDE : Inkoop eigen aandelen | 40204020 Clothing and Accessories | Other subject |
20 Apr 2023 18:00 CEST |
VAN DE VELDE | VAN DE VELDE : Acquisition of treasury shares | 40204020 Clothing and Accessories | Other subject |
20 Apr 2023 17:56 CEST |
CENERGY | Hellenic Cables devient le fournisseur privilégié du Nordseecluster | 50202010 Electrical Components | News contracts |
20 Apr 2023 17:54 CEST |
CENERGY | Hellenic Cables signs as preferred supplier for the Nordseecluster | 50202010 Electrical Components | News contracts |
20 Apr 2023 08:00 CEST |
WERELDHAVE BELGIUM | Trading update 31 March 2023 | 35102045 Retail REITs | New |
20 Apr 2023 08:00 CEST |
WERELDHAVE BELGIUM | Trading update 31 mars 2023 | 35102045 Retail REITs | New |
20 Apr 2023 08:00 CEST |
WERELDHAVE BELGIUM | Trading update 31 Maart 2023 | 35102045 Retail REITs | New |
20 Apr 2023 07:00 CEST |
BIOCARTIS | Press release Biocartis Group NV: Biocartis Reports Results of First Quarter of 2023 | 20101025 Health Services | Commercial results |
20 Apr 2023 07:00 CEST |
BIOCARTIS | Persbericht Biocartis Group NV: Biocartis rapporteert resultaten eerste kwartaal 2023 | 20101025 Health Services | Commercial results |
19 Apr 2023 22:00 CEST |
MDXHEALTH | Foundational LCD Covers Select mdx for Prostate Cancer | 20103010 Biotechnology | Commercial results |
19 Apr 2023 22:00 CEST |
MDXHEALTH | Foundational LCD couvre Select mdx pour le cancer de la prostate | 20103010 Biotechnology | Commercial results |
19 Apr 2023 08:30 CEST |
SOLVAY | Participation notification by Blackrock Inc. | 55201000 Chemicals: Diversified | Corporate life |
19 Apr 2023 08:30 CEST |
SOLVAY | Notification de participation par Blackrock Inc. | 55201000 Chemicals: Diversified | Corporate life |
19 Apr 2023 08:30 CEST |
SOLVAY | Participatiemelding van Blackrock Inc. | 55201000 Chemicals: Diversified | Corporate life |
19 Apr 2023 07:30 CEST |
NEXTENSA | Nextensa: Nextensa demande le permis pour la phase finale du site Tour & Taxis | 35102030 Office REITs | Commercial operations |
19 Apr 2023 07:30 CEST |
NEXTENSA | Nextensa: Nextensa vraagt vergunning aan voor laatste fase Tour & Taxis-site | 35102030 Office REITs | Commercial operations |
19 Apr 2023 07:30 CEST |
NEXTENSA | Nextensa: Nextensa applies for permit for final phase Tour & Taxis site | 35102030 Office REITs | Commercial operations |
18 Apr 2023 19:38 CEST |
CO.BR.HA (D) | Jaarresultaten 2022 | 45101010 Brewers | Corporate life |
18 Apr 2023 18:00 CEST |
HYBRID SOFTWARE GROUP PLC | Hybrid Software Group PLC: Notice of Annual General Meeting | 10101015 Software | Meetings / events |
18 Apr 2023 11:16 CEST |
MITHRA | Mithra releases 2022 Annual Report | 20103015 Pharmaceuticals | Corporate life |
18 Apr 2023 08:37 CEST |
TITAN CEMENT | Programme de rachats d'actions | 50101030 Cement | Other subject |
18 Apr 2023 08:36 CEST |
TITAN CEMENT | Share buyback programme | 50101030 Cement | Other subject |
18 Apr 2023 08:00 CEST |
KBC | KBC Groep: KBC maakt de impact van IFRS 17 op de resultatenrekening bekend met aangepaste vergelijkende resultaten, belangrijke ratio's en verwachtingen op korte en lange termijn. | 30101010 Banks | Commercial results |
18 Apr 2023 08:00 CEST |
KBC | KBC Group: KBC discloses the impact of IFRS 17 on the income statement with restated comparative results, key ratios and short-term and long-term financial guidance | 30101010 Banks | Commercial results |
18 Apr 2023 08:00 CEST |
KBC | KBC Groupe: KBC communique l'impact de la norme IFRS 17 sur le compte de résultats avec des résultats comparatifs, ratios clés et prévisions financières à court et à long terme retraités | 30101010 Banks | Commercial results |
18 Apr 2023 07:00 CEST |
ARGENX SE | argenx Demonstrates Commitment to Redefining Treatment Goals for Generalized Myasthenia Gravis with Multiple Presentations at American Academy of Neurology 2023 Annual Meeting | 20103010 Biotechnology | Other subject |
18 Apr 2023 07:00 CEST |
BIOSENIC | BioSenic receives key European patent from EPO, for further therapeutic development in cancer, infectious and immune diseases | 20103010 Biotechnology | Other subject |
18 Apr 2023 07:00 CEST |
HYLORIS | Hyloris announces submission of Maxigesic® IV packaging data requested by the US FDA | 20103010 Biotechnology | Products and services |
18 Apr 2023 07:00 CEST |
BIOSENIC | BioSenic reçoit un brevet européen clé de l'OEB pour le développement de thérapies contre les cancers, et les maladies infectieuses et immunitaires | 20103010 Biotechnology | Other subject |
18 Apr 2023 07:00 CEST |
HYLORIS | Hyloris annonce la soumission des données relatives au conditionnement de Maxigesic® IV demandées par la FDA aux Etats-Unis | 20103010 Biotechnology | Products and services |
17 Apr 2023 22:30 CEST |
NYXOAH SA | Information on the Total Number of Voting Rights and Shares | 20102010 Medical Equipment | Change in Capital |
17 Apr 2023 22:30 CEST |
NYXOAH SA | Informations sur le Nombre Total de Droits de Vote et d'Actions | 20102010 Medical Equipment | Change in Capital |
17 Apr 2023 22:15 CEST |
EURONAV | Euronav Annual General Meeting of 17 May 2023 | 50206030 Marine Transportation | Other subject |
17 Apr 2023 22:15 CEST |
EURONAV | Euronav – Jaarlijkse Algemene Vergadering van 17 mei 2023 | 50206030 Marine Transportation | Other subject |
17 Apr 2023 18:30 CEST |
IEP INVEST | Gewone algemene vergadering van 24 mei 2023 | 35101010 Real Estate Holding and Development | General meeting / Board Meeting |
17 Apr 2023 18:30 CEST |
IEP INVEST | Buitengewone algemene vergadering van 24 mei 2023 | 35101010 Real Estate Holding and Development | General meeting / Board Meeting |
17 Apr 2023 18:30 CEST |
IEP INVEST | Jaarverslag 2022 | 35101010 Real Estate Holding and Development | Other subject |
17 Apr 2023 18:07 CEST |
GBL | GBL - Transacties op GBL-aandelen 17-04-2023 | 30202000 Diversified Financial Services | Other financial transaction |
17 Apr 2023 18:05 CEST |
GBL | GBL - Transactions sur actions propres 17-04-2023 | 30202000 Diversified Financial Services | Other financial transaction |
17 Apr 2023 18:05 CEST |
ACCENTIS | Oproeping Gewone Algemene Vergadering van 23 mei 2023 | 35101010 Real Estate Holding and Development | General meeting / Board Meeting |
17 Apr 2023 18:04 CEST |
GBL | GBL - Transactions on GBL shares 17-04-2023 | 30202000 Diversified Financial Services | Other financial transaction |
17 Apr 2023 18:00 CEST |
ECONOCOM GROUP | ECONOCOM: Croissance du chiffre d'affaires au 1er trimestre 2023 : +10,3%, dont +4,4% organique | 10101010 Computer Services | Sales, Income, Commercial results |
17 Apr 2023 18:00 CEST |
ECONOCOM GROUP | ECONOCOM: Q1 2023 revenue growth: 10.3% including 4.4% organic growth | 10101010 Computer Services | Sales, Income, Commercial results |
17 Apr 2023 18:00 CEST |
ACCENTIS | Jaarverslag 2022 | 35101010 Real Estate Holding and Development | Other subject |
17 Apr 2023 08:00 CEST |
ARGENX SE | argenx and Genmab Enter Partnership to Advance Antibody Therapies in Immunology and Oncology | 20103010 Biotechnology | Other subject |